InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Baynes Roy D., Director. Insider active across 4 companies, notably Travere Therapeutics, Inc.. Aggregated, 8 disclosures have been recorded. The latest transaction was filed on 11 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
1,307 shares
Common Stock
SEC:0001415889-22-005858:0·
03,000 shares0
Common Stock
SEC:0001209191-22-028685:0·
011,000 shares0
Common Stock
SEC:0001140361-21-020429·
011,000 shares0
Common Stock
SEC:0001140361-21-020429:0·
2,856 shares
Common Stock
SEC:0001415889-21-002767·
2,856 shares
Common Stock
SEC:0001415889-21-002767:0·
03,000 shares0
Common Stock
SEC:0001209191-21-033853·
03,000 shares0
Common Stock
SEC:0001209191-21-033853:0·
8 of 8 declarations
About Baynes Roy D.
Roy D. Baynes is a Board Member at Travere Therapeutics, Inc., Natera, Inc., and Atara Biotherapeutics, Inc. He plays a crucial role in the strategic direction of these companies, contributing to their growth and development.
